Skip to content

EchoGo Heart Failure

by Ultromics Limited

510(k) K222463

EchoGo Heart Failure is a medical device (FDA Class II; FDA product code QUO, Adjunctive Heart Failure Status Indicator) made by Ultromics Limited, cleared under FDA 510(k) K222463 on 23 Nov 2022, active as of 11 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 11 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 11 Oct 2026.

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK222463 Date23 Nov 2022ClearedStatusActive

Official records

From the FDA record

Received by the FDA
15 Aug 2022
FDA decision
23 Nov 2022 (Substantially Equivalent)
FDA review time
100 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K222463 (openFDA), as read on 11 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
QUO
Device class
Class II
Regulation
21 CFR Part 870.2200
Advisory committee
Cardiovascular
FDA decision
SESE Substantially Equivalent

Devices cleared under K222463

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K222463
UDI-DISize and differences
EchoGo Heart Failure 1.0
Ultromics, Ltd.
Heart Failure 1.005060634690041 —On the market

Similar devices

Other devices filed under FDA product code QUO (Adjunctive Heart Failure Status Indicator).

Other devices from Ultromics, Ltd.

See all devices from Ultromics, Ltd. →